» Articles » PMID: 8016893

Receptors for ADP on Human Blood Platelets

Overview
Specialty Pharmacology
Date 1994 Apr 1
PMID 8016893
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that ADP causes aggregation of human blood platelets, and indeed it was the first aggregating agent to be studied, but the ways in which platelets respond to ADP are still relatively obscure. Although it is apparent that increases in intracellular Ca2+ concentrations are of major importance in activating platelets, it is not clearly understood how ADP causes these increases and what other signal transduction mechanisms it uses. It is not even clear whether ADP causes its effects by interacting with only one receptor, or whether multiple receptors for ADP exist on platelets. In this review, Susanna Hourani and David Hall examine some of the conflicting evidence in this field, and draw some tentative conclusions about the number and nature of receptors for ADP on human platelets.

Citing Articles

Platelets camouflaged nanovehicle improved bladder cancer immunotherapy by triggering pyroptosis.

Tian J, Gao M, Zhu J, Xu H, Ji H, Xia D Theranostics. 2024; 14(17):6692-6707.

PMID: 39479459 PMC: 11519802. DOI: 10.7150/thno.99040.


RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets.

Jin J, Mao Y, Thomas D, Kim S, Daniel J, Kunapuli S Biochem Pharmacol. 2008; 77(5):835-44.

PMID: 19073150 PMC: 2745276. DOI: 10.1016/j.bcp.2008.11.017.


The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X Front Biosci. 2007; 13:2588-603.

PMID: 17981736 PMC: 2892180. DOI: 10.2741/2868.


Organosulfur compounds from alliaceae in the prevention of human pathologies.

Tapiero H, Townsend D, Tew K Biomed Pharmacother. 2004; 58(3):183-93.

PMID: 15164729 PMC: 6361170. DOI: 10.1016/j.biopha.2004.01.004.


P2 receptors: new potential players in atherosclerosis.

Di Virgilio F, Solini A Br J Pharmacol. 2002; 135(4):831-42.

PMID: 11861311 PMC: 1573192. DOI: 10.1038/sj.bjp.0704524.